TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling-Reference-Cited by-同舟云学术

TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling

Published:2019-06 Issue: Volume:452 Page:1-13
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Che Yilin,Li Yizhuo,Zheng Fufu,Zou Kun,Li Zongjuan,Chen Manyu,Hu Sheng,Tian Chunfang,Yu Wendan,Guo Wei,Luo Meihua,Deng Wuguo,Zou Lijuan

Funder

National Natural Science Foundation of China

Education Department of Liaoning Province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Current and potential treatments for cervical cancer;Yee;Curr. Cancer Drug Targets,2013

2. Epigenetics and cervical cancer: from pathogenesis to therapy;Fang;Tumour Biol.,2014

3. Prospects of molecularly-targeted therapies for cervical cancer treatment;de Freitas;Curr. Drug Targets,2015

4. Retinoid-dependent antagonism of serum response factor transactivation mediated by transcriptional coactivator proteins;Kim;Oncogene,2001

5. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor;Lee;Mol. Endocrinol.,1995

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering radiotherapy: Harnessing nanomedicines to enhance radiation response and boost antitumor efficacy;Coordination Chemistry Reviews;2024-12

2. Targeting the Molecules in EMT: A Potential Therapeutic Opportunity in Breast Cancer;Current Molecular Medicine;2024-08-19

3. A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer;Molecular Carcinogenesis;2024-07-26

4. NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer;Scientific Reports;2024-07-04

5. Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation;Applied Biochemistry and Biotechnology;2024-06-18